PMID: 6168361Aug 15, 1981Paper

Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction

Cancer
L H EinhornJ P Donohue

Abstract

Platinum combination chemotherapy will regularly produce a 70% complete response rate in testicular cancer. Many patients failing to achieve complete remission can still be rendered disease-free with surgical resection of residual localized disease. Twenty-one patients underwent resection for residual pulmonary lesions and 41 underwent lymphadenectomy for persistent retroperitoneal disease. There were no characteristic radiographic findings for fibrous tissue versus mature teratoma versus carcinoma. Although elevated HCG or AFP levels indicated the presence of carcinoma, negative HCG and AFP did not rule out such a diagnosis as 12 of 22 resected carcinoma patients were seronegative. Of 35 patients, 31 (89%) with fibrous tissue or mature teratomas and all four patients with immature teratomas have been continuously free of disease with a minimal postoperative follow-up time of six months. However, only two of 22 patients with resected carcinomas have been continuously disease-free. Post-operative chemotherapy for mature teratoma or fibrous tissue is probably not necessary. However, we feel that further aggressive chemotherapy is needed in the resected carcinoma patient with at least two courses of platinum combination chemothera...Continue Reading

Citations

Feb 15, 1993·Cancer·D M Gershenson
Jan 1, 1994·Journal of Surgical Oncology·H B TongaonkarM R Kamat
Jan 1, 1990·Seminars in Surgical Oncology·P McCormack
Jan 1, 1983·Cancer Metastasis Reviews·D J Laurence, A M Neville
Jan 1, 1992·International Urology and Nephrology·S CărskyM Májek
Mar 9, 2006·World Journal of Urology·Stephen D W Beck, Richard S Foster
Apr 26, 2002·International Journal of Urology : Official Journal of the Japanese Urological Association·Tsuneharu Miki, Masahiro Nakao
Jul 17, 1998·British Journal of Urology·R RaviW F Hendry
Jul 18, 2014·Nephro-urology Monthly·Seyd Hossein Fattahi MasoumAlireza Goreifi
Jun 5, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Joachim PfannschmidtHendrick Dienemann
Feb 1, 1991·Mayo Clinic Proceedings·T S IngrassiaE C Rosenow
Dec 11, 2002·Chest Surgery Clinics of North America·Lawrence H Einhorn
Oct 21, 2009·BJU International·Christian WinterPeter Albers
Apr 10, 2010·International Journal of Urology : Official Journal of the Japanese Urological Association·Terukazu Nakamura, Tsuneharu Miki
May 1, 1994·The Annals of Thoracic Surgery·E AnyanwuI Vogt-Moykopf
Jan 22, 2005·Critical Reviews in Oncology/hematology·Stefania GoriMaurizio Marangolo
Sep 1, 1985·Cancer Treatment Reviews·S E Bates, D L Longo
Sep 1, 1986·Cancer Treatment Reviews·B D ChesonM A Friedman
Dec 1, 1983·Cancer Treatment Reviews·D M Green
Nov 1, 1983·The American Journal of Medicine·J D Hainsworth, F A Greco
May 1, 1983·European Journal of Cancer & Clinical Oncology·J W Oosterhuis, I Damjanov
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R L JansenC P Vendrik
Jul 1, 1992·Gynecologic Oncology·H G JumeanT Anderson
Jun 1, 1984·European Journal of Cancer & Clinical Oncology·A J SuurmeijerG J Fleuren
Dec 1, 1982·European Journal of Cancer & Clinical Oncology·R A StahelH P Honegger
Oct 1, 1986·Disease-a-month : DM·K D SabbathP Calabresi
Feb 1, 1987·International Journal of Andrology·L H Einhorn
Jan 1, 1987·British Journal of Urology·R EwingR E Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.